Observational studyAnnals of clinical and translational neurology2020

Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.

Brandi L Vollmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.